AQUAMEPHYTON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aquamephyton, and what generic alternatives are available?
Aquamephyton is a drug marketed by Pai Holdings Pharm and is included in one NDA.
The generic ingredient in AQUAMEPHYTON is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aquamephyton
A generic version of AQUAMEPHYTON was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AQUAMEPHYTON?
- What are the global sales for AQUAMEPHYTON?
- What is Average Wholesale Price for AQUAMEPHYTON?
Summary for AQUAMEPHYTON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 3,627 |
| DailyMed Link: | AQUAMEPHYTON at DailyMed |
US Patents and Regulatory Information for AQUAMEPHYTON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | AQUAMEPHYTON | phytonadione | INJECTABLE;INJECTION | 012223-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pai Holdings Pharm | AQUAMEPHYTON | phytonadione | INJECTABLE;INJECTION | 012223-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
